163 related articles for article (PubMed ID: 17404006)
1. Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.
Matthes E; Funk A; Krahn I; Gaertner K; von Janta-Lipinski M; Lin L; Will H; Sirma H
Antimicrob Agents Chemother; 2007 Jul; 51(7):2523-30. PubMed ID: 17404006
[TBL] [Abstract][Full Text] [Related]
2. Cellular pharmacology of the anti-hepatitis B virus agent beta-L-2',3'-didehydro-2',3'-dideoxy-N4-hydroxycytidine: relevance for activation in HepG2 cells.
Matthes E; Bünger H
Antimicrob Agents Chemother; 2010 Jan; 54(1):341-5. PubMed ID: 19917760
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
[TBL] [Abstract][Full Text] [Related]
5. Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosides.
Pai SB; Pai RB; Xie MY; Beker T; Shi J; Tharnish PM; Chu CK; Schinazi RF
Antivir Chem Chemother; 2005; 16(3):183-92. PubMed ID: 16004081
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
Shaw T; Mok SS; Locarnini SA
Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the replication of hepatitis B virus in vitro by a novel 2,6-diaminopurine analog, beta-LPA.
He XX; Chen T; Lin JS; Chang Y; Ye BX
Biochem Biophys Res Commun; 2008 May; 369(2):513-8. PubMed ID: 18284916
[TBL] [Abstract][Full Text] [Related]
8. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric synthesis and antiviral activities of L-carbocyclic 2', 3'-didehydro-2',3'-dideoxy and 2',3'-dideoxy nucleosides.
Wang P; Gullen B; Newton MG; Cheng YC; Schinazi RF; Chu CK
J Med Chem; 1999 Aug; 42(17):3390-9. PubMed ID: 10464025
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
11. Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase.
von Janta-Lipinski M; Costisella B; Ochs H; Hübscher U; Hafkemeyer P; Matthes E
J Med Chem; 1998 Jun; 41(12):2040-6. PubMed ID: 9622545
[TBL] [Abstract][Full Text] [Related]
12. [Effect and mechanism of beta-L-D4A (a novel nucleoside analog) against hepatitis B virus].
Wu JM; Lin JS; Xie N; Jiang FC; Liang KH
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):268-70. PubMed ID: 12773236
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus.
Hernandez-Santiago B; Placidi L; Cretton-Scott E; Faraj A; Bridges EG; Bryant ML; Rodriguez-Orengo J; Imbach JL; Gosselin G; Pierra C; Dukhan D; Sommadossi JP
Antimicrob Agents Chemother; 2002 Jun; 46(6):1728-33. PubMed ID: 12019082
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
[TBL] [Abstract][Full Text] [Related]
15. Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
Volz T; Lütgehetmann M; Allweiss L; Warlich M; Bierwolf J; Pollok JM; Petersen J; Matthes E; Dandri M
Antivir Ther; 2012; 17(4):623-31. PubMed ID: 22368233
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
[TBL] [Abstract][Full Text] [Related]
17. Antiviral L-nucleosides specific for hepatitis B virus infection.
Bryant ML; Bridges EG; Placidi L; Faraj A; Loi AG; Pierra C; Dukhan D; Gosselin G; Imbach JL; Hernandez B; Juodawlkis A; Tennant B; Korba B; Cote P; Marion P; Cretton-Scott E; Schinazi RF; Sommadossi JP
Antimicrob Agents Chemother; 2001 Jan; 45(1):229-35. PubMed ID: 11120971
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of 5'-O-carbonate-2',3'-dideoxy-3'-thiacytidine prodrugs against hepatitis B virus in HepG2 2.2.15 cells.
Gagey D; Ravetti S; Castro EF; Gualdesi MS; Briñon MC; Campos RH; Cavallaro LV
Int J Antimicrob Agents; 2010 Dec; 36(6):566-9. PubMed ID: 20947311
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis B virus production by modified 2',3'-dideoxy-thymidine and 2',3'-dideoxy-5-methylcytidine derivatives. In vitro and in vivo studies.
Matthes E; von Janta-Lipinski M; Will H; Schröder HC; Merz H; Steffen R; Müller WE
Biochem Pharmacol; 1992 Apr; 43(7):1571-7. PubMed ID: 1314607
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine.
Zhu YL; Dutschman DE; Liu SH; Bridges EG; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1805-10. PubMed ID: 9661025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
